Filter

351 - 360 of 372 Results

  • KFF COVID-19 Vaccine Monitor: March 2023

    Poll Finding

    As the COVID-19 public health emergency comes to an end, about half of adults say they would be likely to get an annual COVID-19 booster. Around one in three adults don't think they have ever had COVID-19, nor have they ever tested positive for it, and they primarily attribute this to taking precautions such as avoiding crowds.

  • Half of the Public Would Likely Get an Annual COVID-19 Vaccine Offered Like a Flu Shot

    News Release

    More than three years into the COVID-19 pandemic, about half (53%) the public says they would likely get an annual COVID-19 vaccine if offered similar to an annual flu shot, the latest KFF COVID-19 Vaccine Monitor finds. This includes about a third (32%) who would be “very likely” to do so. The findings provide a window into the potential uptake of an annual COVID-19 vaccine, which the Food and Drug Administration has raised as a…

  • Poll: Most Americans Encounter Health Misinformation, and Most Aren’t Sure Whether It’s True or False 

    News Release

    A new KFF survey reveals the broad reach of health misinformation, with at least four in 10 people saying that they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence. Relatively small shares say that each of those false claims are “definitely true”, ranging from as few as 3% who definitively believe that COVID-19 vaccines have been proven to cause infertility to as many as 18% who definitively believe armed…

  • Most Parents Haven’t Heard Misinformation About the Measles Vaccine though Significant Shares Are Uncertain About the Validity of Claims

    News Release

    As rates of childhood vaccination decline and with measles on the rise again, a KFF Health Misinformation Tracking Poll, fielded in late February, examines the extent to which adults have heard and believe misinformation about the measles vaccine. The poll also examines the public’s views of the U.S. government and social media companies’ role in moderating false health claims online. While most of the public—including parents—haven’t heard misinformation about the measles vaccine, many are uncertain…

  • Most Black and Hispanic Adults Expect to Get the New COVID-19 Vaccine, Though Most White Adults Don’t

    News Release

    The latest KFF COVID-19 Vaccine Monitor survey reveals that half (51%) of all adults nationally say they “definitely” or “probably” will not get the latest COVID-19 vaccine, with many saying that they aren’t worried about catching the virus. One in five (20%) say that they’ve already gotten the new vaccine that became available in September, with an additional 28% saying they “definitely” or “probably” will get the new shot. The rest say they “definitely” or…

  • Year in Review: 10 Health Policy Issues for 2023

    Fact Sheet

    This fact sheet offers a look back at 10 issues that KFF tracked closely during 2023 in its polling, policy analysis and journalism, including summaries of major findings and news stories.

  • New Nationwide Poll by the Kaiser Family Foundation and The Undefeated Reveals Distrust of the Health Care System Among Black Americans

    News Release

    Half of African Americans say they will not take a coronavirus vaccine KFF/The Undefeated poll shows disparate views on health care between Black and white America Poll results published on The Undefeated beginning today The Kaiser Family Foundation (KFF) and The Undefeated have conducted a joint nationwide survey that explores the views and experiences of African Americans during the coronavirus pandemic. Despite the disproportionate impact of the virus on Black communities, 49 percent of African…

  • Private Health Coverage of COVID-19: Key Facts and Issues

    Issue Brief

    New federal legislation will require most private health plans to cover testing for the coronavirus with no cost sharing. Some states have adopted similar requirements for insurers they regulate, and many private insurance companies will voluntarily expand coverage for testing. However, some private coverage will not be subject to these requirements. To date, fewer changes have been adopted or considered with respect to treatment for complications from the disease. This brief reviews current coverage standards…